Publication not explained
Read the Original
This page is a summary of: Metabolism of the Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor Seliciclib (R-Roscovitine) in Vitro and in Vivo, Drug Metabolism and Disposition, November 2007, American Society for Pharmacology & Experimental Therapeutics (ASPET), DOI: 10.1124/dmd.107.019232.
You can read the full text:
Be the first to contribute to this page